New webinar
What are the reimbursement pathways for innovative digital health technologies?
Innovative digital health solutions are finding their ways into routine patient care in the US and Europe, and different payers are starting to cover software-based healthcare products just like they…
View webinar
Featured resources
presentation
Deep Dive into FDA’s Expedited Programs for Drug Development
If you are developing products for serious and life-threatening illnesses with unmet medical needs, there are several mechanisms offered by…
publication
Recent Revisions to Legislation Impacting the Pharmaceutical Industry in Switzerland
With the objective of harmonizing pharmaceutical regulatory practices and legislation with Europe, the Swiss Medicines Agency (Swissmedic) recently conducted an…
presentation
Overview of EU Regulatory Landscape for Regenerative Medicines
Regenerative medicines, part of the so-called Advanced Therapy Medicinal Products (ATMPs) in Europe, are cell-based medicinal products aiming at replacing…
All our resources
More resources
publication
Possible Contexts of Use for In Silico trials methodologies: a consensus- based review
The term “In Silico Trial” indicates the use of computer modelling and simulation to evaluate the safety and efficacy of…
publication
Advanced therapies in the EU: challenges with HTA and real-world evidence
Market access aims to make a health technology not only available and affordable for every patient, but also profitable for…
webinar
How to use Scientific Advice to enhance your product development strategy
Scientific Advice (SA) is one of the important interactions a developer can have with a regulatory agency (national or European…
Case study
Conducting a Pediatric Investigation Plan (PIP) at Late Clinical Stage
A US based Biotech company was unaware of the EU’s requirement for a Pediatric Investigation Plan (PIP) until their product…
blog
2021 Advancing Regulatory Science at FDA: What are the focus areas
The Food and Drug Administration (FDA) conducts research in regulatory science to improve regulatory decision-making by developing new tools and approaches to…
webinar
Ask the Experts: How to have an effective INTERACT meeting with the FDA
INTERACT meeting is an informal non-binding consultation with the CBER at FDA. It allows sponsors to obtain preliminary informal consultation…
blog
The implementation of the Clinical Trial Regulation (Regulation (EU) No 536/2014): where do we stand?
While the Regulation (EU) No 536/2014 was adopted back in 2014, its application in the European Union depends on the…
webinar
What are the reimbursement pathways for innovative digital health technologies?
Innovative digital health solutions are finding their ways into routine patient care in the US and Europe, and different payers…
